S. Suntheralingam Et Al. , "Evaluation of Risk Prediction Models to Identify Cancer Therapeutics Related Cardiac Dysfunction in Women with HER2+ Breast Cancer," Journal of Clinical Medicine , vol.11, no.3, 2022
Suntheralingam, S. Et Al. 2022. Evaluation of Risk Prediction Models to Identify Cancer Therapeutics Related Cardiac Dysfunction in Women with HER2+ Breast Cancer. Journal of Clinical Medicine , vol.11, no.3 .
Suntheralingam, S., Fan, C. S., Calvillo-Argüelles, O., Abdel-Qadir, H., Amir, E., & Thavendiranathan, P., (2022). Evaluation of Risk Prediction Models to Identify Cancer Therapeutics Related Cardiac Dysfunction in Women with HER2+ Breast Cancer. Journal of Clinical Medicine , vol.11, no.3.
Suntheralingam, Sivisan Et Al. "Evaluation of Risk Prediction Models to Identify Cancer Therapeutics Related Cardiac Dysfunction in Women with HER2+ Breast Cancer," Journal of Clinical Medicine , vol.11, no.3, 2022
Suntheralingam, Sivisan Et Al. "Evaluation of Risk Prediction Models to Identify Cancer Therapeutics Related Cardiac Dysfunction in Women with HER2+ Breast Cancer." Journal of Clinical Medicine , vol.11, no.3, 2022
Suntheralingam, S. Et Al. (2022) . "Evaluation of Risk Prediction Models to Identify Cancer Therapeutics Related Cardiac Dysfunction in Women with HER2+ Breast Cancer." Journal of Clinical Medicine , vol.11, no.3.
@article{article, author={Sivisan Suntheralingam Et Al. }, title={Evaluation of Risk Prediction Models to Identify Cancer Therapeutics Related Cardiac Dysfunction in Women with HER2+ Breast Cancer}, journal={Journal of Clinical Medicine}, year=2022}